Phase Holographic aktie (PHI) | Pressmeddelande - Börskollen
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

•Rapportsäsong: Här är bolagen som rapporterar idag den 22 november

Pressmeddelanden från Phase Holographic

 Bevaka pressreleaser
Kurs från TradingView
StartNyheterPressreleaserRiktkurserInsynshandelBlankningAnalyserBloggarVideosPodcasts

Kallelse till extra bolagsstämma i Phase Holographic Imaging PHI AB (publ) den 2 december 2024

Phase Holographic Imaging PHI AB (publ), 556542-7811 (“Bolaget”) håller extra bolagsstämma den 2 december 2024 kl.

Cision • 12 Nov 21:53

Notice of Extraordinary General Meeting in Phase Holographic Imaging PHI AB (publ) 2 December 2024

Phase Holographic Imaging PHI AB (publ), 556542-7811 (the “Company”) will hold an Extraordinary General Meeting on 2 December 2024 at 15.

Cision • 12 Nov 21:52

PHI resolves on a fully secured rights issue of shares of approximately SEK 64.3 million

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, JAPAN, CANADA, NEW ZEALAND, SOUTH AFR...

Cision • 12 Nov 21:49

Rättelse med Revisorsyttrande: Årsredovisning 2023/24

Rättelse: Pressmeddelandet från 2024-10-29 med bolagets årsredovisning innehöll en felaktig version av årsredovisningen samt saknade revisio...

Cision • 12 Nov 11:25

Adopting the final Annual Report

PHI intends to convene a general meeting to adopt the annual report for the fiscal year 2023/2024 and to amend resolutions regarding electio...

Cision • 11 Nov 21:01

Rättelse: Årsredovisning 2023/24

Rättelse: Pressmeddelandet från 2024-10-29 med bolagets årsredovisning innehöll en felaktig version av årsredovisningen samt saknade revisio...

Cision • 11 Nov 20:25

PHI's new CEO to BioStock: "I am excited to lead us forward with new energy"

Anders Månsson was recently appointed CEO of Phase Holographic Imaging.

Cision • 06 Nov 08:52

Bulletin from the annual general meeting of Phase Holographic Imaging PHI AB (publ)

Phase Holographic Imaging PHI AB (publ), reg.no 556542-7811 (the “Company”) held its annual general meeting on 31 October 2024.

Cision • 01 Nov 08:12

Årsredovisning 2023/24

Årsredovisning 2023/24

Cision • 29 Oct 10:40

PHI secures a loan from Altium SA

Phase Holographic Imaging PHI AB ("PHI") announces that the Company has been provided a loan of SEK 7 million from the main shareholder Alti...

Cision • 28 Oct 14:08

PHI AB’s warrant exercise registered at the Swedish Companies Registration Office

Phase Holographic Imaging PHI AB ("PHI" or "Company") today announces that the new shares from the exercise of warrants of series TO 4 have ...

Cision • 18 Oct 08:58

PHI appoints Anders Månsson as new CEO

The board of Phase Holographic Imaging (PHI) has today appointed Anders Månsson as the new CEO of PHI as of November 1, 2024.

Cision • 17 Oct 13:13

Phase Holographic Imaging PHI AB receives approx. SEK 5.2 million through warrant exercise

On 3 October 2024, the exercise period for warrants of series TO 4, which were issued in connection with Phase Holographic Imaging PHI AB’s ...

Cision • 04 Oct 15:50

BioStock: PHI accelerates growth with record order

Phase Holographic Imaging recently received its most significant order from Altium, comprising 20 HoloMonitor systems and additional compone...

Cision • 02 Oct 09:00

Notice of Annual General Meeting in Phase Holographic Imaging PHI AB (publ)

The shareholders of Phase Holographic Imaging PHI AB (publ), reg.

Cision • 30 Sep 16:20

Kallelse till årsstämma i Phase Holographic Imaging PHI AB (publ)

Aktieägarna i Phase Holographic Imaging PHI AB (publ), org.

Cision • 30 Sep 16:20

The last day of trading in warrants of series TO 4 is on 1 October 2024

The 1st of October 2024 is the last day of trading in warrants of series TO 4, which were issued in connection with Phase Holographic Imagin...

Cision • 26 Sep 09:33

PHI announces significant order agreement from Altium for 20 HoloMonitor systems

Phase Holographic Imaging (PHI) is excited to announce a significant order agreement from Altium for 20 HoloMonitor systems, which will be s...

Cision • 16 Sep 13:52

Interim Report 1 2024/25

Interim Report 1 2024/25

Cision • 16 Sep 13:50

The exercise period for warrants of series TO 4 commences today

Today is the first day for the exercise of Phase Holographic Imaging PHI AB's ("PHI" or "Company") warrants of series TO 4 ("TO 4") which we...

Cision • 12 Sep 08:55

The exercise price for warrants of series TO 4 has been set to SEK 4.63 per new share

Phase Holographic Imaging PHI AB ("PHI" or "the Company") hereby announces that the exercise price for the warrants of series TO 4 (”TO 4”),...

Cision • 11 Sep 09:36

Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ)

Phase Holographic Imaging PHI AB (publ) (“PHI” or the “Company”) held an extraordinary general meeting on 2 September 2024.

Cision • 02 Sep 15:24

BioStock: PHI’s CEO comments on the approved US listing

Phase Holographic Imaging has been approved for a dual US listing in addition to its primary listing on the Swedish Spotlight market.

Cision • 21 Aug 08:49

PHI enters the US capital market – shares now also traded on OTCQB

Phase Holographic Imaging (PHI) is thrilled to announce its official approval for listing on the OTCQB Venture Market in the U.

Cision • 16 Aug 08:14

New date: Notice of extraordinary general meeting in Phase Holographic Imaging PHI AB (publ)

Phase Holographic Imaging PHI AB (publ), reg. no. 556542-7811 (the "Company"), will hold an extraordinary general meeting on 2 September at ...

Cision • 14 Aug 10:32

Nytt datum: Kallelse till extra bolagsstämma i Phase Holographic PHI Imaging AB (publ)

Phase Holographic PHI Imaging AB (publ), org. nr. 556542-7811 (”Bolaget”), håller extra bolagsstämma den 2 september 2024 kl.

Cision • 14 Aug 10:30

PHI postpones the extraordinary general meeting until September 2, 2024

PHI postpones the extraordinary general meeting until September 2, 2024

Cision • 14 Aug 10:00

Kallelse till extra bolagsstämma i Phase Holographic PHI Imaging AB

Phase Holographic PHI Imaging AB (publ), org. nr. 556542-7811 (”Bolaget”), håller extra bolagsstämma den 19 augusti 2024 kl.

Cision • 22 Jul 10:01

Notice of extraordinary general meeting in Phase Holographic Imaging PHI AB

Phase Holographic Imaging PHI AB (publ), reg. no. 556542-7811 (the "Company"), will hold an extraordinary general meeting on 19 August at 14...

Cision • 22 Jul 10:00

Board member Leland Foster resigns due to personal reasons

Phase Holographic Imaging (PHI), announces the resignation of esteemed board member Leland Foster.

Cision • 22 Jul 09:59

BioStock: PHI aims for US listing

Swedish Medtech Phase Holographic Imaging is making significant strides in the United States, establishing itself at the forefront of the ra...

Cision • 11 Jul 08:15

PHI applies for listing on OTCQB in the United States

Phase Holographic Imaging (PHI) is pursuing a dual listing on the US-based OTCQB Venture Market (“OTCQB”) to provide US-based investors with...

Cision • 08 Jul 08:52

Year-end report 2023/24

Year-end report 2023/24

Cision • 26 Jun 08:04

BioStock: PHI grows its network of collaborations

Phase Holographic Imaging has entered into a partnership with the University College London, the first partnership in a hospital setting to ...

Cision • 19 Jun 08:42

PHI bolsters Nordic sales presence with new distribution agreement between Altium and Kem-En-Tec Nordic

Phase Holographic Imaging (PHI) is pleased to announce a new distribution agreement between its global distribution partner, Altium, and Kem...

Cision • 18 Jun 10:02

PHI expands to Spanish and Portuguese markets through Altium's new subcontract with Paralab

Phase Holographic Imaging (PHI) is pleased to announce a strategic expansion into the Spanish and Portuguese markets, facilitated by a new s...

Cision • 13 Jun 11:32

PHI partners with University College London to use HoloMonitor in a first clinical research project

Phase Holographic Imaging (PHI) is excited to announce a strategic partnership with University College London (UCL).

Cision • 11 Jun 09:32

PHI terminates agreement regarding liquidity provider

Phase Holographic Imaging (PHI) today announces that the Company has terminated the liquidity provider agreement with Pareto Securities AB.

Cision • 04 Jun 09:02

PHI to BioStock: “It’s the right moment to capitalize on regenerative medicine momentum.”

Medtech company Phase Holographic Imaging recently secured a loan facility of SEK 7 million.

Cision • 23 May 09:21

PHI secures a loan facility of in total SEK 7 million

Phase Holographic Imaging PHI AB ("PHI" or the "Company") announces that the Company has secured a loan facility of in total SEK 7 million f...

Cision • 17 May 08:09

PHI announces conference schedule for spring 2024

Phase Holographic Imaging (PHI) is pleased to announce a strategic activity schedule for spring 2024, during which PHI will participate in s...

Cision • 02 Apr 10:20

Interim Report 3 2023/24

Interim Report 3 2023/24

Cision • 27 Mar 08:20

BioStock: Shift to regenerative medicine increases growth prospects for PHI

With a sharp focus on expanding its market to regenerative medicine, medtech company PHI has a growth trajectory that is on a notable upward...

Cision • 20 Mar 08:53

Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ)

Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ)

Cision • 14 Mar 11:05

Shaping the future of Regenerative Medicine – PHI’s vision for QPI in Cell Therapy Manufacturing

Phase Holographic Imaging (PHI) is pleased to present a comprehensive opinion piece detailing the versatility and potential the Company sees...

Cision • 11 Mar 14:14

New Distributor Partner Manager at Altium set to enhance global sales for PHI

Phase Holographic Imaging (PHI) is conveying the news that its global distributor, Altium S.

Cision • 05 Mar 10:46

Kallelse till extra bolagsstämma i Phase Holographic Imaging PHI AB

Phase Holographic Imaging PHI AB (publ), 556542–7811 (”Bolaget”) håller extra bolagsstämma den 14 mars 2024 kl.

Cision • 26 Feb 10:55

Notice of extraordinary general meeting in Phase Holographic Imaging PHI AB

Phase Holographic Imaging PHI AB (publ), 556542-7811 (the "Company") will hold an extraordinary general meeting on 14 March 2024 at 10.

Cision • 26 Feb 10:54

PHI to BioStock: “We aim to revolutionize the regenerative medicine market “

A year ago, Patrik Eschricht assumed the role of CEO at PHI, heralding the shift towards regenerative medicine and a commitment to enhancing...

Cision • 21 Feb 09:07

PHI presents at the Redeye Regenerative Medicine & Cell Therapy 2024

Phase Holographic Imaging (PHI) announces its participation in the Redeye Regenerative Medicine and Cell Therapy event on Wednesday, Februar...

Cision • 07 Feb 14:56

PHI announces extraordinary quarter sales of about 5MSEK — marks the highest ever in Company history

Phase Holographic Imaging (PHI) is excited to announce that preliminary Q3 net sales are summing up to approximately 5MSEK.

Cision • 30 Jan 15:05

Interim Report 2 2023/24

Interim Report 2 2023/24

Cision • 21 Dec 2023 13:16

PHI appoints Pareto Securities AB to act as a liquidity provider for the Company’s share

Phase Holographic Imaging (PHI) has appointed Pareto Securities as the Company’s liquidity provider.

Cision • 15 Dec 2023 11:45

PHI granted patent on synthetic antibodies in the EU

Phase Holographic Imaging (PHI) announces that the Company has been granted a patent on synthetic antibodies from the European Patent Office...

Cision • 07 Dec 2023 14:48

Directed issue registered at the Companies Registration Office

Phase Holographic Imaging PHI AB (“PHI” or “the Company”) Board of Directors’ proposal on a directed issue to Altium S.

Cision • 23 Nov 2023 11:47

Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ)

Phase Holographic Imaging PHI AB (publ) (“PHI” or the “Company”) held an extraordinary general meeting on November 15, 2023.

Cision • 15 Nov 2023 11:15

BioStock: PHI’s CEO reflects on the Company’s momentum

Medtech company PHI has experienced a dynamic year, with multiple significant advancements resulting in a 230 per cent surge in the company’...

Cision • 14 Nov 2023 08:17

BioStock: Altium fuels PHI’s forward drive

PHI’s largest investor, Altium S.A., has intensified its support for the company with a directed share issue of 9.

Cision • 09 Nov 2023 08:35

Korrigerad: Kallelse till extra bolagsstämma i Phase Holographic Imaging PHI AB

Korrigeringen härrör sig till fel veckodag för extra bolagsstämman vid tidigare publicering.

Cision • 02 Nov 2023 14:52

Bulletin from the annual general meeting of Phase Holographic Imaging PHI AB (publ)

Phase Holographic Imaging PHI AB (publ) held its annual general meeting on the 27th of October 2023.

Cision • 27 Oct 2023 17:28

Kallelse till extra bolagsstämma i Phase Holographic Imaging PHI AB

Aktieägarna i Phase Holographic Imaging PHI AB (publ), 556542–7811 (”Bolaget”), kallas härmed till extra bolagsstämma tisdagen den 15 novemb...

Cision • 27 Oct 2023 11:21

Major shareholder acquires PHI’s convertible loan from Formue Nord

Phase Holographic Imaging (PHI) informs the market that PHI’s largest investor, Altium S.

Cision • 26 Oct 2023 18:00

PHI’s Board of Directors proposes signing Altium as global distributor partner

Phase Holographic Imaging (PHI) informs the market that PHI’s Board of Directors decided to propose signing Altium S.

Cision • 26 Oct 2023 17:59

PHI’s Board of Directors proposes a Direct Issue of shares of 9.9 MSEK to Altium

Phase Holographic Imaging (PHI) informs the market that to raise capital, PHI’s Board of Directors proposes a direct issue of 2 374 820 new ...

Cision • 26 Oct 2023 17:58

PHI endorses WFIRM as Finalist for NSF’s $160 Million Innovation Grant

Phase Holographic Imaging (PHI) proudly stands behind the Wake Forest Institute for Regenerative Medicine (WFIRM) as they contend as a final...

Cision • 12 Oct 2023 11:28

Årsredovisning 2022/23

Styrelsen och verkställande direktören för Phase Holographic Imaging PHI AB (publ), organisationsnummer 556542-7811 och med säte i Lund, avg...

Cision • 06 Oct 2023 14:04

Kallelse till årsstämma i Phase Holographic Imaging PHI AB (publ)

Aktieägarna i Phase Holographic Imaging PHI AB (publ), 556542–7811, kallas härmed till årsstämma fredagen den 27 oktober 2023 kl.

Cision • 28 Sep 2023 11:14

Notice of Annual General Meeting in Phase Holographic Imaging PHI AB (publ)

The shareholders of Phase Holographic Imaging PHI AB (publ), 556542-7811, are hereby invited to the annual general meeting on Friday 27 Octo...

Cision • 28 Sep 2023 11:13

Interim Report 1 2023/24

Interim Report 1 2023/24

Cision • 20 Sep 2023 12:18

Notice that Interim Report 1 2023/24 will be published on September 20, 2023

Notice that Interim Report 1 2023/24 will be published on September 20, 2023

Cision • 15 Sep 2023 11:07

PHI AB annual general meeting moved to 27 October 2023

The board of Phase Holographic Imaging (PHI) AB has decided to move the company’s annual general meeting from 12 October 2023 to 27 October ...

Cision • 11 Sep 2023 11:48

BioStock: PHI links up with two regenerative medicine networks

In 2023, Phase Holographic Imaging has solidified its footprint in regenerative medicine.

Cision • 07 Sep 2023 09:22

PHI Strengthens Commitment to Regenerative Medicine through ARM and ATMP Sweden Membership

Phase Holographic Imaging (PHI) becomes a member of the leading international advocacy organization Alliance for Regenerative Medicine (ARM)...

Cision • 05 Sep 2023 09:02

BioStock: PHI charts a bold course to impact regenerative medicine

Swedish medtech company PHI released its year-end report last week, outlining its transformative phase and strategic focus on regenerative m...

Cision • 06 Jul 2023 08:21

European Patent Office intends to grant PHI patent on synthetic antibodies

Phase Holographic Imaging AB (PHI) announces today that the European Patent Office (EPO) intends to grant a patent on synthetic antibodies.

Cision • 04 Jul 2023 08:36

BioStock: PHI’s CEO reflects on global roadshow success

During the early summer, medical technology company PHI embarked on a global tour to showcase their latest HoloMonitor products, lab instrum...

Cision • 28 Jun 2023 10:24

Year-end Report 2022/23

Year-end Report 2022/23

Cision • 26 Jun 2023 10:33

Notice that Interim Report 4 2022/23 will be published on June 26, 2023

Phase Holographic Imaging changes the date for publication of Interim Report 4 2022/23 to June 26, 2023.

Cision • 21 Jun 2023 14:18

PHI’s new HoloMonitor M4FL premiers at major scientific conferences

Phase Holographic Imaging (PHI) introduces the HoloMonitor M4FL system to the global scientific community at two major scientific conference...

Cision • 24 May 2023 09:55

PHI AB’s warrant exercise registered with the Swedish Companies Registration Office

Phase Holographic Imaging PHI AB (“PHI” or the “Company”) today announces that the new shares from the exercise of warrants of series TO 3 h...

Cision • 22 May 2023 13:35

Kommuniké från extra bolagsstämma i Phase Holographic Imaging PHI AB (publ)

Phase Holographic Imaging PHI AB (publ) höll den 9 maj 2023 extra bolagsstämma.

Cision • 09 May 2023 17:27

Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ)

Phase Holographic Imaging PHI AB (publ) held an extraordinary general meeting on 9 May 2023.

Cision • 09 May 2023 17:26

TO 3 Warrants Subscribed to 100 %

On 2 May 2023, the exercise period for warrants of series TO 3 (“TO 3”), which were issued in connection with Phase Holographic Imaging PHI ...

Cision • 04 May 2023 12:58

BioStock: PHI on how TO 3 proceeds will be used

On May 2, the redemption period of Phase Holographic Imaging’s warrants of series TO 3 ends.

Cision • 28 Apr 2023 09:32

Last day of trading in warrants of series TO 3 is 27 April 2023

Thursday, 27 April 2023, is the last day of trading in warrants of series TO 3, which were issued in connection with Phase Holographic Imagi...

Cision • 24 Apr 2023 11:10

Insider Acquisitions in Phase Holographic Imaging

CEO Patrik Eschricht, chairman Peter Egelberg and deputy board member Ann Christine Egelberg has recently acquired additional holdings in Ph...

Cision • 24 Apr 2023 08:35

PHI enters into underwriting commitment with Altium in ongoing exercise of TO 3 warrants

Phase Holographic Imaging PHI AB ("PHI" or the "Company") hereby announces that the Company’s largest shareholder Altium SA (“Altium”) and P...

Cision • 21 Apr 2023 08:04

Kallelse till extra bolagsstämma i Phase Holographic Imaging PHI AB

Aktieägarna i Phase Holographic Imaging PHI AB, 556542–7811 (”Bolaget”), kallas härmed till extra bolagsstämma tisdagen den 9 maj 2023 kl.

Cision • 20 Apr 2023 11:54

Altium S.A. exercised all their obtained warrants TO 3

Phase Holographic Imaging (PHI) announces that Altium S.

Cision • 19 Apr 2023 09:27

The exercise period for warrants of series TO 3 begins today

Today is the first day of the exercise period for Phase Holographic Imaging PHI AB’s (“PHI” or the “Company”) warrants of series TO 3, which...

Cision • 11 Apr 2023 14:27

The subscription price for warrants of series TO 3 has been set at SEK 3.78 per share

Phase Holographic Imaging PHI AB (“PHI” or the “Company”) hereby announces the subscription price for the exercise of warrants of series TO ...

Cision • 05 Apr 2023 13:50

BioStock: PHI´s CEO comments on latest advancements

In 2022, medtech company Phase Holographic Imaging conducted a rights issue that added over 57 million SEK to its coffers.

Cision • 29 Mar 2023 14:18

Interim Report 3 2022/23

Interim Report 3 2022/23

Cision • 28 Mar 2023 10:45

Clarification Regarding Potential Collaborations

Clarification Regarding Potential Collaborations

Cision • 28 Mar 2023 08:15

Notice that Interim Report 3 2022/23 will be published already on March 28, 2023

Phase Holographic Imaging changes the date for publication of Interim Report 3 2022/23 to March 28, 2023.

Cision • 27 Mar 2023 10:35

PHI creates a subsidiary for the anticipated EU patent concerning synthetic antibodies

Phase Holographic Imaging (PHI) announces today that the European Patent Office intends to grant application EP329447 Molecularly Imprinted ...

Cision • 21 Mar 2023 10:00

BioStock: PHI catches eye of major investor

The private Swiss Distributor and Investment Company Altium has acquired a corner of Swedish medtech company Phase Holographic Imaging, maki...

Cision • 10 Mar 2023 10:06

Swiss-based Altium acquires major stake in PHI

Phase Holographic Imaging (PHI) announces that Altium S.

Cision • 08 Mar 2023 13:00

BioStock: PHI kommenterar bolagets nya seniora positioner

Phase Holographic Imaging har utsett sin grundare och tidigare vd, Peter Egelberg, till styrelseordförande.

Cision • 15 Feb 2023 08:32

BioStock: PHI comments on the new senior positions in the company

Phase Holographic Imaging has appointed its founder and former CEO, Peter Egelberg, as Chairman of the Board, while the company’s former CFO...

Cision • 15 Feb 2023 08:32